Stocks and Investing Stocks and Investing
Mon, April 25, 2022
[ 12:00 AM ] - WOPRAI
Alexandra Steiger Downgraded (TDUP) to Hold on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Garrett Nelson Upgraded (TSLA) to Strong Buy on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (TSCO) at Hold with Decreased Target to $220 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Stevenson Downgraded (TREX) to Hold and Decreased Target to $68 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Rafe Jadrosich Initiated (TREX) at Sell and Held Target at $60 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Richard Shane Maintained (TRTX) at Hold with Decreased Target to $12 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Michael Cyprys Maintained (TROW) at Hold with Decreased Target to $170 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Paul Newsome Maintained (TRV) at Hold with Increased Target to $190 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Alex Scott Maintained (TRV) at Hold with Increased Target to $190 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Timothy Daley Downgraded (TMO) to Sell and Decreased Target to $525 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Stephen Baxter Maintained (THC) at Buy with Decreased Target to $90 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Joshua Wilson Maintained (AVY) at Buy with Decreased Target to $185 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Timothy Daley Maintained (AVTR) at Buy with Decreased Target to $33 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Jon Arfstrom Maintained (AXP) at Hold with Increased Target to $200 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
James Fotheringham Maintained (AXP) at Hold with Decreased Target to $167 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Savanthi Syth Maintained (AZUL) at Buy with Decreased Target to $22 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Jeffrey Stevenson Downgraded (AZEK) to Hold and Decreased Target to $25 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Terrell Maintained (BANC) at Hold with Increased Target to $22 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Andrew Terrell Maintained (BANR) at Hold with Increased Target to $66 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
David Strauss Maintained (CACI) at Buy with Increased Target to $340 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Thomas Allen Downgraded (BYD) to Hold and Decreased Target to $76 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Matthew Harrison Downgraded (ALNY) to Hold and Decreased Target to $178 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Joseph Spak Maintained (ALV) at Buy with Decreased Target to $97 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Vijay Rakesh Maintained (ALV) at Strong Buy with Decreased Target to $90 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Colin Langan Maintained (ALV) at Hold with Decreased Target to $74 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Blayne Curtis Maintained (AMAT) at Hold with Decreased Target to $150 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Sam Choe Maintained (AMH) at Hold with Increased Target to $44 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Chris Caso Upgraded (AMD) to Strong Buy and Held Target at $160 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Suraj Kalia Upgraded (BLFS) to Buy and Held Target at $28 on, Apr 25th, 2022
[ 12:00 AM ] - WOPRAI
Matthew Harrison Upgraded (BMRN) to Buy and Increased Target to $113 on, Apr 25th, 2022

Matthew Harrison Upgraded (BMRN) to Buy and Increased Target to $113 on, Apr 25th, 2022


Published on 2024-10-27 20:36:37 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Upgraded "BioMarin Pharmaceutical Inc." (BMRN) to Buy and Increased Target from $96 to $113 on, Apr 25th, 2022.

Matthew has made no other calls on BMRN in the last 4 months.



There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew

  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $125 on, Thursday, February 24th, 2022
Contributing Sources